Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A multi-disciplinary team of scientists led by Oxford University has been shortlisted along with eight other groups, to the final stages of Cancer Research UK's global Grand Challenge – an ambitious series of £20m cancer grants tackling some of the toughest questions in cancer research.

Led by the University of Oxford’s Professor Freddie Hamdy, and including researchers from three different countries, the team plans to distinguish between a lethal prostate cancer and one that doesn’t need treatment. They will combine detailed molecular analysis of existing samples with novel lines of investigation in new patient groups – aiming to understand what biological features are present at the earliest point when cancer spreads or becomes resistant to treatment.

The overall goal is to reduce unnecessary treatment of ‘safe’ cancers, and ensure rapid and thorough treatment of those likely to be lethal. The team hope to develop and test a ‘molecular checklist’ of features that will make this a reality *.

The team will now receive seed-funding to draft their full research proposal, and the winning proposal will be announced in autumn 2016.

The Grand Challenge award aims to revolutionise how we diagnose, prevent and treat cancer by uniting teams of the best scientists around the world to come up with answers to crucial questions about how to save more lives from cancer.

Sir Harpal Kumar, Cancer Research UK’s chief executive, said: “The calibre of applications for our Grand Challenge is evidence of the remarkable global talent working in cancer research. It’s inspiring to see scientists of all disciplines and nations unite in the fight against the disease.”

Dr Rick Klausner, chair of the Grand Challenge advisory panel, said: “With so many exceptional teams proposing novel approaches, it was no easy task to pick our shortlist, but we’re delighted with the teams we’ve selected and look forward to hearing more about their plans to beat the toughest questions in cancer. At least one of these teams will be awarded the first ever Grand Challenge award later this year.”

Oxford University’s Professor Freddie Hamdy said: “Prostate cancer is one of the most common, but also most controversial cancers to manage. We are now set to answer the most difficult question of all: How can we recognise aggressive disease as early as possible, in order to treat the right patient, at the right time, with the right treatment option? With the exciting world-leading team we have put together, and unprecedented material from thousands of generous patients, we will rise to this challenge put to us by Cancer Research UK.”

 

For media enquiries about the team and their research contact the University of Oxford news office: news.office@admin.ox.ac.uk or 01865 270046.

For media enquiries about Cancer Research UK’s Grand Challenge award contact Emily Head in the Cancer Research UK press office on 020 3469 8300 or, out of hours, on 07050 264 059.

Similar stories

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

Omair Shariq wins Best Clinical Paper at the American Association of Endocrine Surgeons 2021 Annual Meeting

Dr Omair Shariq, a DPhil student and clinical research fellow in the Nuffield Department of Surgical Sciences (NDS) and Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), has received the 2021 Best Presentation for Clinical Research award during the 41st Annual Meeting of the American Association of Endocrine Surgeons (AAES), which was held virtually on 25-27 April 2021.

Artificial intelligence tool for streamlining pathology workflow

A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

Professor Peter McCulloch receives NIHR Senior Investigator Award

We are delighted to announce that Professor Peter McCulloch of the Nuffield Department of Surgical Sciences has been awarded the title of NIHR Senior Investigator.

New Cochrane evidence explores treatment options for chronic ear disease

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Blog posts

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.

In memory of Sue Bonnington

Pete Holding shares his memories of a much-loved colleague, Sue Bonnington. Based in Leicester, Sue worked remotely for the Nuffield Department of Surgical Sciences (NDS) as a ProtecT study Lead Research Nurse from 2002 to 2017.